Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses
- 3 May 2005
- Vol. 23 (32) , 4101-4109
- https://doi.org/10.1016/j.vaccine.2005.03.037
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Phylogenetic comparison of the genus Lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genesArchiv für die gesamte Virusforschung, 2002
- Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxisVaccine, 2001
- Evidence of TwoLyssavirusPhylogroups with Distinct Pathogenicity and ImmunogenicityJournal of Virology, 2001
- Recent booksThe Library, 1999
- The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssavirusesResearch in Virology, 1996
- Avirulent mutants of rabies virus and their use as live vaccineTrends in Microbiology, 1993
- Rabies Virus-specific Human T Cell Clones Provide Help for an in vitro Antibody Response against Neutralizing Antibody-inducing Determinants of the Viral GlycoproteinJournal of General Virology, 1989
- Comparative study of two human diploid rabies vaccines administered with antirabies globulinVaccine, 1988
- Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studiesVaccine, 1985
- Characteristics of 11 Rabies Virus Isolates in Mice: Titers and Relative Invasiveness of Virus, Incubation Period of Infection, and Survival of Mice with SequelaeThe Journal of Infectious Diseases, 1977